Drug profile · INN
polidocanol
ASCLERA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
polidocanol (ASCLERA) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
INN polidocanol
Brand ASCLERA
Route INTRAVENOUS
Formulation SOLUTION
Frequently asked questions
What is polidocanol?
polidocanol (ASCLERA) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for polidocanol?
ASCLERA is a marketed brand name for polidocanol. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of polidocanol?
polidocanol has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.